Redpoint Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.12M | Sell |
4,187
-47
| -1% | -$12.6K | 0.16% | 152 |
|
|
2022
Q2 | $863K | Hold |
4,234
| – | – | 0.1% | 243 |
|
|
2022
Q1 | $892K | Hold |
4,234
| – | – | 0.09% | 267 |
|
|
2021
Q4 | $1.02M | Sell |
4,234
-67
| -2% | -$16.1K | 0.08% | 286 |
|
|
2021
Q3 | $1.22M | Sell |
4,301
-103
| -2% | -$29.1K | 0.1% | 229 |
|
|
2021
Q2 | $1.53M | Sell |
4,404
-85
| -2% | -$29.4K | 0.12% | 199 |
|
|
2021
Q1 | $1.26M | Hold |
4,489
| – | – | 0.11% | 220 |
|
|
2020
Q4 | $1.1M | Sell |
4,489
-377
| -8% | -$92.3K | 0.11% | 202 |
|
|
2020
Q3 | $1.38M | Sell |
4,866
-9,475
| -66% | -$2.69M | 0.15% | 163 |
|
|
2020
Q2 | $3.84M | Sell |
14,341
-1,870
| -12% | -$500K | 0.21% | 107 |
|
|
2020
Q1 | $5.13M | Sell |
16,211
-7,679
| -32% | -$2.43M | 0.32% | 73 |
|
|
2019
Q4 | $7.09M | Sell |
23,890
-1,026
| -4% | -$304K | 0.35% | 63 |
|
|
2019
Q3 | $5.8M | Buy |
24,916
+3,083
| +14% | +$718K | 0.31% | 74 |
|
|
2019
Q2 | $5.11M | Buy |
21,833
+3,041
| +16% | +$711K | 0.27% | 87 |
|
|
2019
Q1 | $4.44M | Buy |
18,792
+2,169
| +13% | +$513K | 0.22% | 110 |
|
|
2018
Q4 | $5M | Sell |
16,623
-3,486
| -17% | -$1.05M | 0.29% | 77 |
|
|
2018
Q3 | $7.11M | Sell |
20,109
-530
| -3% | -$187K | 0.36% | 66 |
|
|
2018
Q2 | $5.99M | Sell |
20,639
-165
| -0.8% | -$47.9K | 0.33% | 74 |
|
|
2018
Q1 | $5.7M | Buy |
20,804
+273
| +1% | +$74.8K | 0.32% | 74 |
|
|
2017
Q4 | $6.54M | Buy |
+20,531
| New | +$6.54M | 0.36% | 59 |
|